Professional credentials provide a veneer of respectability.
Without those, nobody would have invested.
Just because someone was considered legitimate and well respected within their industry at one point, it doesn't mean that they are now - it provides the perfect cover for an OTC stock. How else could this charade continue for 10+ years with ZERO progress?
Price is now almost back to where the run began back in January 2021 - other than Pink nothing tangible has been delivered in over 14 months, unless you count empty words.
Imagine Dalton is a little wealthier though...